Immunohistochemistry MUM1 Test: Advanced Cancer Diagnosis
Understanding the Immunohistochemistry MUM1 Test
The Immunohistochemistry MUM1 Test represents a cutting-edge diagnostic approach in cancer pathology, specifically designed to detect the Multiple Myeloma Oncogene 1 (MUM1) protein expression in tissue specimens. This sophisticated laboratory technique plays a pivotal role in modern oncology by providing precise molecular information that guides accurate cancer classification and treatment planning.
What Does the MUM1 Test Measure?
The Immunohistochemistry MUM1 Test specifically identifies and quantifies the presence of the MUM1/IRF4 protein, which serves as a critical marker in lymphoma pathology. This test utilizes advanced antibody-based staining techniques to visualize protein expression patterns within tissue samples, enabling pathologists to:
- Detect MUM1 protein expression in B-cell lymphomas
- Differentiate between germinal center and activated B-cell subtypes
- Assist in classifying diffuse large B-cell lymphomas (DLBCL)
- Identify specific lymphoma subtypes for targeted therapy
Who Should Consider This Test?
The Immunohistochemistry MUM1 Test is particularly valuable for patients presenting with:
- Unexplained lymph node enlargement or swelling
- Suspected lymphoma based on clinical presentation
- Previous inconclusive biopsy results requiring further characterization
- Need for precise lymphoma subtyping for treatment selection
- Monitoring disease progression or treatment response in known lymphoma cases
Clinical Indications and Symptoms
Patients experiencing persistent symptoms such as night sweats, unexplained weight loss, fever, fatigue, or multiple enlarged lymph nodes should discuss this testing option with their oncologist or hematologist. The test becomes particularly important when initial pathology reports suggest B-cell lymphoma but require further subclassification.
Benefits of the Immunohistochemistry MUM1 Test
Choosing the Immunohistochemistry MUM1 Test provides numerous advantages for both patients and healthcare providers:
- Precise Diagnosis: Enables accurate classification of lymphoma subtypes
- Treatment Guidance: Helps oncologists select appropriate targeted therapies
- Prognostic Information: Provides valuable insights into disease behavior and expected outcomes
- Minimized Misdiagnosis: Reduces the risk of incorrect lymphoma classification
- Personalized Medicine: Supports development of individualized treatment plans
Technical Excellence and Reliability
Our laboratory maintains the highest standards in immunohistochemistry testing, utilizing state-of-the-art equipment and validated protocols to ensure consistent, reliable results. Each test is performed by experienced pathologists and technologists specializing in hematopathology and cancer diagnostics.
Understanding Your Test Results
Interpreting Immunohistochemistry MUM1 Test results requires specialized expertise. Generally, results are categorized as:
- Positive MUM1 Expression: Typically indicates activated B-cell-like phenotype in DLBCL, which may influence treatment decisions
- Negative MUM1 Expression: Often associated with germinal center B-cell-like phenotype
- Variable Expression Patterns: May indicate specific lymphoma subtypes requiring additional testing
Your healthcare provider will discuss the clinical significance of your specific results and how they impact your diagnosis and treatment plan. The interpretation considers multiple factors including clinical history, other test results, and overall pathology findings.
Test Pricing and Availability
| Test Description | Regular Price | Discount Price |
|---|---|---|
| Immunohistochemistry MUM1 Test | $112 USD | $88 USD |
Turnaround Time and Sample Requirements
We offer efficient testing services with the following turnaround times:
- Standard Tissue Block: 5 days
- Tissue Biopsy: 5 days
- Large Complex Tissue: 7 days
- Sample Submission: Daily by 6 PM
Sample Collection and Preparation
For optimal results, please submit tumor tissue in 10% formal-saline OR formalin-fixed paraffin-embedded block. Ship samples at room temperature and include a copy of the histopathology report, biopsy site information, and complete clinical history.
Nationwide Testing Availability
We proudly serve patients across the United States with testing facilities in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more locations. Our network ensures accessible, high-quality diagnostic services for patients nationwide.
Take Control of Your Health Today
Don’t let uncertainty about your diagnosis delay proper treatment. The Immunohistochemistry MUM1 Test provides the clarity needed for effective cancer management. Our team of specialists is ready to assist you with comprehensive testing and expert interpretation.
Ready to Schedule Your Test?
Contact our dedicated patient care team to book your Immunohistochemistry MUM1 Test or to discuss your testing needs with our specialists.
Call or WhatsApp: +1(267) 388-9828
Our representatives are available to answer your questions, assist with scheduling, and provide guidance on sample collection and submission requirements.
Note: This test should be ordered and interpreted by qualified healthcare professionals. Insurance coverage may vary, and patients are encouraged to verify benefits with their insurance provider.
